Literature DB >> 23134420

RCAN1 regulates vesicle recycling and quantal release kinetics via effects on calcineurin activity.

Mark P Zanin1, Kimberly D Mackenzie, Heshan Peiris, Melanie A Pritchard, Damien J Keating.   

Abstract

We have previously shown that Regulator of Calcineurin 1 (RCAN1) regulates multiple stages of vesicle exocytosis. However, the mechanisms by which RCAN1 affects secretory vesicle exocytosis and quantal release kinetics remain unknown. Here, we use carbon fibre amperometry to detect exocytosis from chromaffin cells and identify these underlying mechanisms. We observe reduced exocytosis with repeated stimulations in chromaffin cells over-expressing RCAN1 (RCAN1(ox)), but not in wild-type (WT) cells, indicating a negative effect of RCAN1 on vesicle recycling and endocytosis. Acute exposure to calcineurin inhibitors, cyclosporine A and FK-506, replicates this effect in WT cells but has no additional effect in RCAN1(ox) cells. When we chronically expose WT cells to cyclosporine A and FK-506 we find that catecholamine release per vesicle and pre-spike foot (PSF) signal parameters are decreased, similar to that in RCAN1(ox) cells. Inhibiting calcineurin activity in RCAN1(ox) cells has no additional effect on the amount of catecholamine release per vesicle but further reduces PSF signal parameters. Although electron microscopy studies indicate these changes are not because of altered vesicle number or distribution in RCAN1(ox) cells, the smaller vesicle and dense core size we observe in RCAN1(ox) cells may underlie the reduced quantal release in these cells. Thus, our results indicate that RCAN1 most likely affects vesicle recycling and quantal release kinetics via the inhibition of calcineurin activity.
© 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23134420     DOI: 10.1111/jnc.12086

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

Review 1.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

2.  Identification of unique release kinetics of serotonin from guinea-pig and human enterochromaffin cells.

Authors:  Ravinarayan Raghupathi; Michael D Duffield; Leah Zelkas; Adrian Meedeniya; Simon J H Brookes; Tiong Cheng Sia; David A Wattchow; Nick J Spencer; Damien J Keating
Journal:  J Physiol       Date:  2013-10-07       Impact factor: 5.182

3.  Regulator of Calcineurin 1 helps coordinate whole-body metabolism and thermogenesis.

Authors:  David Rotter; Heshan Peiris; D Bennett Grinsfelder; Alyce M Martin; Jana Burchfield; Valentina Parra; Christi Hull; Cyndi R Morales; Claire F Jessup; Dusan Matusica; Brian W Parks; Aldons J Lusis; Ngoc Uyen Nhi Nguyen; Misook Oh; Israel Iyoke; Tanvi Jakkampudi; D Randy McMillan; Hesham A Sadek; Matthew J Watt; Rana K Gupta; Melanie A Pritchard; Damien J Keating; Beverly A Rothermel
Journal:  EMBO Rep       Date:  2018-11-02       Impact factor: 8.807

4.  RCAN1 overexpression exacerbates calcium overloading-induced neuronal apoptosis.

Authors:  Xiulian Sun; Yili Wu; Bruno Herculano; Weihong Song
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

5.  Leucine-Rich Repeat Kinase 2 (LRRK2) Stimulates IL-1β-Mediated Inflammatory Signaling through Phosphorylation of RCAN1.

Authors:  Kyung A Han; Lang Yoo; Jee Y Sung; Sun A Chung; Ji W Um; Hyeyoung Kim; Wongi Seol; Kwang C Chung
Journal:  Front Cell Neurosci       Date:  2017-05-11       Impact factor: 5.505

6.  Serotonin-secreting enteroendocrine cells respond via diverse mechanisms to acute and chronic changes in glucose availability.

Authors:  Leah Zelkas; Ravi Raghupathi; Amanda L Lumsden; Alyce M Martin; Emily Sun; Nick J Spencer; Richard L Young; Damien J Keating
Journal:  Nutr Metab (Lond)       Date:  2015-12-15       Impact factor: 4.169

7.  RCAN1 regulates mitochondrial function and increases susceptibility to oxidative stress in mammalian cells.

Authors:  Heshan Peiris; Daphne Dubach; Claire F Jessup; Petra Unterweger; Ravinarayan Raghupathi; Hakan Muyderman; Mark P Zanin; Kimberly Mackenzie; Melanie A Pritchard; Damien J Keating
Journal:  Oxid Med Cell Longev       Date:  2014-06-09       Impact factor: 6.543

8.  Distinct fusion properties of synaptotagmin-1 and synaptotagmin-7 bearing dense core granules.

Authors:  Tejeshwar C Rao; Daniel R Passmore; Andrew R Peleman; Madhurima Das; Edwin R Chapman; Arun Anantharam
Journal:  Mol Biol Cell       Date:  2014-06-18       Impact factor: 4.138

9.  Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Jamie R K Marland; Karen J Smillie; Michael A Cousin
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  RCAN1 Knockdown Reverts Defects in the Number of Calcium-Induced Exocytotic Events in a Cellular Model of Down Syndrome.

Authors:  Jacqueline Vásquez-Navarrete; Agustín D Martínez; Stéphane Ory; Ximena Baéz-Matus; Arlek M González-Jamett; Sebastián Brauchi; Pablo Caviedes; Ana M Cárdenas
Journal:  Front Cell Neurosci       Date:  2018-07-06       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.